Company / Shareholders' Equity
West Pharmaceutical Services Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$3.2B
FY2025
5-year range
$1.6B / $3.2B
FY2021-FY2025
Trend
+18.4%
vs FY2024
Sector context
#39 of 161
Health Care
What the data says
West Pharmaceutical Services's shareholders' equity of $3.2B is higher than 76% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 10 years, ranging from $957M in FY2016 to $3.2B in FY2025.
Based on SEC 10-K filings.
$3.2B in FY2025 with a 5-year CAGR of +17.9%. Top quartile in the Health Care sector.
Improved from $2.9B to $3.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +19.6%
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Sector benchmark
-37.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.9%, indicating consistent growth.
- In FY2025, shareholders' equity increased 18.4% year-over-year.
- Ranks #39 out of 161 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.2B | +18.4% |
| FY2024 | $2.7B | -6.9% |
| FY2023 | $2.9B | +55.4% |
| FY2022 | $1.9B | +17.9% |
| FY2021 | $1.6B | +12.7% |
| FY2020 | $1.4B | -11.2% |
| FY2019 | $1.6B | +12.7% |
| FY2018 | $1.4B | +9.1% |
| FY2017 | $1.3B | +33.8% |
| FY2016 | $956.9M | +5.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026